Analysts are making bold mid-cap calls today. Two upgrades stand out alongside a notable target cut.
MOS received a full upgrade from the analyst consensus. The Mosaic Company, a fertiliser producer with a $6.9B market cap, saw its average target price edge to $27.72. Short interest sits at a modest 5.5% of free float. Analysts are betting on a recovery in fertiliser demand.
STE also received an upgrade. STERIS, the sterilisation and infection control specialist, now has a consensus average target of $269.71. The move reflects improved confidence in healthcare infrastructure spending.
On the downside, CRL took a target price cut. Charles River Laboratories' consensus target slipped to $208.80 from $209.00. The pre-clinical research firm carries 7.2% short interest. Weak biopharma spending remains a drag.
AKAM attracted multiple rating changes simultaneously. The CDN and cloud security firm has 11.3% of its float sold short — among the higher readings in large-cap tech. Its average consensus target rose slightly to $153.63. Bears and bulls are clearly divided.
CAT saw its average target climb to $913.29 from $903.68. Analysts remain broadly bullish on infrastructure and construction equipment demand. The upgrade in target comes despite ongoing tariff uncertainty.
This is not financial advice.
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
